Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas
about
Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma CellsBrain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations.Neurotrophic factors for the investigation and treatment of movement disorders.Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell linesPharmacologic resistance in prolactinoma patients.Growth factors in the pathogenesis of prolactin-secreting tumors.
P2860
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Nerve growth factor and bromoc ...... iptine-resistant prolactinomas
@ast
Nerve growth factor and bromoc ...... iptine-resistant prolactinomas
@en
type
label
Nerve growth factor and bromoc ...... iptine-resistant prolactinomas
@ast
Nerve growth factor and bromoc ...... iptine-resistant prolactinomas
@en
prefLabel
Nerve growth factor and bromoc ...... iptine-resistant prolactinomas
@ast
Nerve growth factor and bromoc ...... iptine-resistant prolactinomas
@en
P2093
P2860
P356
P1476
Nerve growth factor and bromoc ...... iptine-resistant prolactinomas
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1995.520
P407
P577
1995-12-01T00:00:00Z